跳至主要内容
临床试验/NCT04728906
NCT04728906Unknown不适用

Targeted-cell Therapy Using Epithelial Stem Cells and Patients' Cardiomyocytes Loaded in Amnion Bilayer to Regenerate Myocardial Infarction Post COVID-19 Complication

Rumah Sakit Pusat Angkatan Darat Gatot Soebroto6 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2022年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
10
试验地点
6
主要终点
Change of the ischemic burden (%)

研究概览

简要总结

Myocardial infarction (MI), as one of the many complications of COVID-19, is one of the contributing patients of patients' death. This study attempts on developing an intervention of MI by regenerating damaged cardiomyocytes due to insufficiency of oxygen in cardiac muscles, triggered by an occlusion of coronary artery (MI). Heart patch developed from amnion bilayer seeded with amnion epithelial stem cells and patient's autologous cardiomyocytes is used as a therapy. Patients who undergo bypass (CABG) surgery are given heart patch, and then patients condition are observed by ECG, Echo, blood test, and radiology (technetium-99m)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 40 - 60 years old
  • Ischemic burden >10% and ischemic gradients red-violet
  • Ischemic area is not feasible to be grafted (bypass) due to other conditions such as diffusion and deep intramuscular vascularization
  • Ejection fraction >30-35%
  • Euro score <8

排除标准

  • Scanning of Technetium-99 showed black colored ischemic area
  • Patients undergoing other procedures other than bypass such as valve repair
  • Chronic kidney failure
  • Patients have went through several bypass surgeries prior
  • Patients are still COVID-19 positive
  • Immunocompromised patients

结局指标

主要结局

Change of the ischemic burden (%)

时间窗: Comparison from the imaging within 3 months before intervention, and after 6 months post treatment.

Diagnosed by MRI

Change in the regional heart wall motion abnormality

时间窗: Observation of the heart wall motion by 1 week before intervention and 4 - 12 - 24 weeks after intervention

measured using Echocardiographic

次要结局

  • Change of the electrocardiographic wave(Observation of electrocardiogram records by 1 week before intervention and 4 - 12 - 24 weeks after intervention)
  • Change of the ejection fraction(Observation of the heart motion by 1 week before intervention and 4 - 12 - 24 weeks after intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Normalina Sandora

Normalina Sandora, MD, MSc, PhD

Rumah Sakit Pusat Angkatan Darat Gatot Soebroto

研究点 (6)

Loading locations...

相似试验

Heart Patch for Myocardial Infarction COVID-19 | 临床试验